Agenus | Cassa E Equivalenti





Cassa E Equivalenti Cambiamento Data
AbbVie USD 5.63B 838M 2025-09
Agenus USD 3.46M 6.08M 2025-09
Amgen USD 9.13B 316M 2025-12
AstraZeneca USD 8.14B 1.08B 2025-09
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Celldex Therapeutics USD 36.04M 12.99M 2025-09
CSL USD 2.16B 633M 2025-06
Dynavax Technologies USD 160.25M 61.15M 2025-09
Eli Lilly USD 9.79B 6.42B 2025-09
Gilead Sciences USD 7.33B 2.19B 2025-09
GlaxoSmithKline GBP 3.3B 303M 2025-09
Glaxosmithkline GBP 3.3B 303M 2025-09
Incyte USD 3.58B 650.78M 2025-12
Intrexon USD 9.34M 1.77M 2024-06
J&J USD 18.23B 10.35B 2025-09
Jiangsu Hengrui CNY 40.36B 4.24B 2025-09
Karyopharm Therapeutics USD 37.67M 1.05M 2025-09
MacroGenics USD 80.13M 50.56M 2025-09
Merck EUR 1.17B 161M 2025-06
Merck USD 18.17B 10.16B 2025-09
Novartis USD 9.56B 2.9B 2025-09
Novavax USD 268.02M 14.28M 2025-09
Pfizer USD 1.34B 295M 2025-09
Regeneron Pharmaceuticals USD 18.87B 16.36B 2025-12
Rigel Pharmaceuticals USD 48.53M 4.87M 2025-09
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Veracyte USD 315.57M 96.07M 2025-09


Agenus Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.